Satish C. Rao

Head of Orexin, Senior Director, US Medical Affairs at Takeda

Role
Head of Orexin, Senior Director, Us Medical Affairs at Takeda
Location
Boston, MA, US
LinkedIn followers
500 followers
Healthcare & Human ServicesView LinkedIn profile

About Satish C. Rao

I am a neurologist-neuroscientist trained at the Mayo Clinic, triple boarded (neurology, clinical neurophysiology/EEG, sleep medicine) and have expertise in clinical development, medical affairs & digital biomarkers.I practiced epileptology, sleep medicine & general neurology for 18 years and have experience in clinical development and medical affairs in both small biotechnology and large pharma settings.In regards to my biotechnology experience, I was the former CEO and founder of Olivecell. Olivecell was an audio-video digital biomarker company. The digital biomarkers were discovered with artificial intelligence. The biomarker products were developed for neuropsychiatric disorders with a focus on Parkinson’s disease. I lead all clinical development plans at Olivecell. The IP and technology were acquired in 2021.After the exit, I transitioned into medical affairs at Takeda Pharmaceuticals as head of epilepsy in the US and then promoted to the head of orexin for US medical affairs. This has given me broad exposure to both clinical development and medical affairs activity required from phase 2-4 to drug launch. This includes leading the creation of the medical launch plan of oveporexton.Lastly, I have a background in biomedical research and academic neurology. This includes hands-on experience with DNA sequencing as a Howard Hughes Medical Fellow, molecular neuroscience research in spinal cord injury during my master’s degree, and multiple research projects and publications in clinical neurology, epilepsy/EEG, and sleep medicine.

Experience

  1. Head of Orexin, Senior Director, Us Medical Affairs

    Takeda

    Jul 2024 — Present · Boston, MA, US

    In this new role, I have franchise level responsibility for Takeda\'s multi-asset orexin programs. I am accountable for leading the overall US medical strategy for the orexin programs (ranging from ph1 to ph4). This includes management of other executives, budget forecasting and management, evidence generation planning, health economic modeling, designing the medical communications strategy, medical education, sponsorships/grants, and taking the lead in cross-functional internal engagement and external engagements with thought leaders, patient advocacy, professional societies and other stakeholders. I will also participate in life cycle management of multiple compounds and business development. This role allowed me to lead the medical launch plan of oveporexton.

Education

  • University of Louisville

    Bachelor of Arts - BA, Biology

  • Mayo Clinic Alix School of Medicine

    Adult Neurology Residency

  • Mayo Clinic Alix School of Medicine

    Sleep Medicine Fellowship

  • University of Louisville

    Master's degree, Neuroscience

  • University of Louisville

    Doctor of Medicine - MD

  • Mayo Clinic Alix School of Medicine

    Preliminary Internal Medicine (internship)

  • Mayo Clinic Alix School of Medicine

    Epilepsy / EEG Fellowship

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Satish C. Rao — Head of Orexin, Senior Director, Us Medical Affairs at Takeda in Boston, MA, US | Unifers